Why do people take the MOTS-c peptide? Mostly because early research links it to metabolism, which is how your body turns food into energy. A peptide is a short chain of amino acids, the building blocks of protein. Here is what MOTS-c is, what studies show, and where it stands with the FDA.
What MOTS-c Is
MOTS-c is a peptide of 16 amino acids. A review in Frontiers in Endocrinology explains that it is encoded in the DNA of mitochondria, the small structures inside cells that produce energy. That makes it a mitochondrial-derived peptide, which is a signaling molecule that mitochondria help create. The review reports that the first 11 amino acids are highly conserved across 14 species, including humans and mice, which means evolution has kept them nearly unchanged. Under metabolic stress, MOTS-c moves toward the cell nucleus in a process that depends on AMPK, an enzyme that senses cellular energy levels. MOTS-c is not an approved medicine for any condition.
Why People Are Interested
Interest comes from mouse studies. The review reports that MOTS-c prevented obesity in mice fed a high-fat diet, and that in old mice it improved age-related insulin resistance, a state in which cells respond poorly to insulin, the hormone that moves sugar out of blood. After seven days, their insulin sensitivity matched that of young mice. In people, researchers measured MOTS-c during exercise: muscle levels rose about 11.9-fold afterward, and blood levels rose about 1.6-fold during exercise before returning to baseline. The review describes no human trials of giving MOTS-c and says no effective clinical application method has been developed yet. Animal results often do not carry over to people.
Where It Stands With the FDA
MOTS-c is not FDA-approved. In 2026, the FDA moved to remove it from Category 2, its list of compounding ingredients with significant safety concerns, and sent it to an advisory committee for review with obesity and osteoporosis as the listed uses. On July 23, 2026, that committee voted 7 to 5, with two abstentions, to recommend adding it to the bulk drug list. Legal analysts note that the vote is advice only, adding a substance to the list is not the same as approval, and formal rulemaking could take years. Until a rule is final, these peptides do not meet the usual compounding categories, and no listing would show that MOTS-c is effective for any particular use.
Frequently Asked Questions
What Is MOTS-c?
MOTS-c is a 16 amino acid peptide encoded in mitochondrial DNA. Mitochondria are the energy-producing structures inside your cells. Researchers study it for roles in metabolism, insulin sensitivity, and exercise.
Is MOTS-c FDA-Approved?
No. MOTS-c is not an FDA-approved medicine. An FDA advisory committee voted in July 2026 to recommend adding it to a compounding list. That vote is advice and not an approval.
What Does Human Research Show About MOTS-c?
Studies found that MOTS-c levels in muscle and blood rise with exercise and tend to be lower with age. A 2023 review describes no human trials of MOTS-c injections.
Why Is Mouse Research Not Enough?
Mice and people differ in metabolism, dosing, and safety. Many animal findings never repeat in human trials, so researchers want controlled studies in people before drawing conclusions about benefit or risk.
Good to Know
Safety of injected MOTS-c in people is not established, because the review describes no human intervention trials and no effective clinical delivery method. The authors also note open questions about how the peptide enters cells without breaking down. Products sold online may vary in purity, and compounded drugs are not FDA-approved.
Take the Next Step With a Licensed Clinician
Curious about metabolism and energy options? Start with an online assessment. An independent licensed clinician reviews your health history and goals, explains what is and is not supported by evidence, and discusses which options, if any, are appropriate for you. You set the pace for each next step.
This article is for education only and is not medical advice.